Potential Utilization of a Polysaccharide from the Marine Algae Gayralia oxysperma , as an Antivenom for Viperidae Snakebites

Worldwide, snakebites have serious implications for human health. The administration of antivenom is the official treatment used to reverse the toxic activities of envenomation. However, this therapy is not efficient to treat the local effects, leading to the amputation or deformity of affected limb...

Full description

Saved in:
Bibliographic Details
Published in:Marine drugs Vol. 16; no. 11; p. 412
Main Authors: da Silva, Ana Cláudia Rodrigues, Duarte, Maria Eugenia Rabello, Noseda, Miguel Daniel, Ferreira, Luciana Garcia, Cassolato, Juliana Emanuela Fogari, Sanchez, Eladio Flores, Fuly, Andre Lopes
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 27-10-2018
MDPI
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Worldwide, snakebites have serious implications for human health. The administration of antivenom is the official treatment used to reverse the toxic activities of envenomation. However, this therapy is not efficient to treat the local effects, leading to the amputation or deformity of affected limbs. As such, alternative treatments are needed. Here, we analyze the ability of a polysaccharide from the green marine alga (Go3) to inhibit the effects of venom from and . or venoms were incubated together with sulfated heterorhamnans from Go3, and the in vitro (coagulation, proteolytic, and hemolytic) and in vivo (hemorrhagic, myotoxic, edematogenic, and lethal) activities of venoms were assessed. Additionally, Go3 was injected before and after the injection of venoms, and the toxic activities were further tested. When incubated with the venoms, Go3 inhibited all activities, though results varied with different potencies. Moreover, Go3 neutralized hemorrhagic, myotoxic, and edematogenic activities when injected before or after injection with and venom. Go3 also blocked the coagulation of plasma in mice caused by the venoms in an ex vivo test. Therefore, Go3 has the potential to be used as antivenom for and bites, notably exhibiting higher efficacy on venom.
AbstractList Worldwide, snakebites have serious implications for human health. The administration of antivenom is the official treatment used to reverse the toxic activities of envenomation. However, this therapy is not efficient to treat the local effects, leading to the amputation or deformity of affected limbs. As such, alternative treatments are needed. Here, we analyze the ability of a polysaccharide from the green marine alga Gayralia oxysperma (Go3) to inhibit the effects of venom from Bothrops jararaca and Lachesis muta. B. jararaca or L. muta venoms were incubated together with sulfated heterorhamnans from Go3, and the in vitro (coagulation, proteolytic, and hemolytic) and in vivo (hemorrhagic, myotoxic, edematogenic, and lethal) activities of venoms were assessed. Additionally, Go3 was injected before and after the injection of venoms, and the toxic activities were further tested. When incubated with the venoms, Go3 inhibited all activities, though results varied with different potencies. Moreover, Go3 neutralized hemorrhagic, myotoxic, and edematogenic activities when injected before or after injection with B. jararaca and L. muta venom. Go3 also blocked the coagulation of plasma in mice caused by the venoms in an ex vivo test. Therefore, Go3 has the potential to be used as antivenom for B. jararaca and L. muta bites, notably exhibiting higher efficacy on L. muta venom.
Worldwide, snakebites have serious implications for human health. The administration of antivenom is the official treatment used to reverse the toxic activities of envenomation. However, this therapy is not efficient to treat the local effects, leading to the amputation or deformity of affected limbs. As such, alternative treatments are needed. Here, we analyze the ability of a polysaccharide from the green marine alga (Go3) to inhibit the effects of venom from and . or venoms were incubated together with sulfated heterorhamnans from Go3, and the in vitro (coagulation, proteolytic, and hemolytic) and in vivo (hemorrhagic, myotoxic, edematogenic, and lethal) activities of venoms were assessed. Additionally, Go3 was injected before and after the injection of venoms, and the toxic activities were further tested. When incubated with the venoms, Go3 inhibited all activities, though results varied with different potencies. Moreover, Go3 neutralized hemorrhagic, myotoxic, and edematogenic activities when injected before or after injection with and venom. Go3 also blocked the coagulation of plasma in mice caused by the venoms in an ex vivo test. Therefore, Go3 has the potential to be used as antivenom for and bites, notably exhibiting higher efficacy on venom.
Worldwide, snakebites have serious implications for human health. The administration of antivenom is the official treatment used to reverse the toxic activities of envenomation. However, this therapy is not efficient to treat the local effects, leading to the amputation or deformity of affected limbs. As such, alternative treatments are needed. Here, we analyze the ability of a polysaccharide from the green marine alga Gayralia oxysperma (Go3) to inhibit the effects of venom from Bothrops jararaca and Lachesis muta . B. jararaca or L. muta venoms were incubated together with sulfated heterorhamnans from Go3, and the in vitro (coagulation, proteolytic, and hemolytic) and in vivo (hemorrhagic, myotoxic, edematogenic, and lethal) activities of venoms were assessed. Additionally, Go3 was injected before and after the injection of venoms, and the toxic activities were further tested. When incubated with the venoms, Go3 inhibited all activities, though results varied with different potencies. Moreover, Go3 neutralized hemorrhagic, myotoxic, and edematogenic activities when injected before or after injection with B. jararaca and L. muta venom. Go3 also blocked the coagulation of plasma in mice caused by the venoms in an ex vivo test. Therefore, Go3 has the potential to be used as antivenom for B. jararaca and L. muta bites, notably exhibiting higher efficacy on L. muta venom.
Author Sanchez, Eladio Flores
Fuly, Andre Lopes
Cassolato, Juliana Emanuela Fogari
da Silva, Ana Cláudia Rodrigues
Noseda, Miguel Daniel
Duarte, Maria Eugenia Rabello
Ferreira, Luciana Garcia
AuthorAffiliation 2 Department of Biochemistry and Molecular Biology, Federal University of Paraná, Curitiba, Paraná 81531-980, Brazil; mdn@ufpr.br (M.D.N.); lugarciaferreira@gmail.com (L.G.F.); jcassolato@yahoo.com.br (J.E.F.C.)
3 Laboratory of Biochemistry of Proteins from Animal Venoms, Research and Development Center, Ezequiel Dias Foundation, Belo Horizonte, Minas Gerais 30510-010, Brazil; eladiooswaldo@gmail.com
1 Department of Molecular and Cellular Biology, Federal Fluminense University, Niterói, Rio de Janeiro 24020-141, Brazil; anacrs1@yahoo.com.br
AuthorAffiliation_xml – name: 1 Department of Molecular and Cellular Biology, Federal Fluminense University, Niterói, Rio de Janeiro 24020-141, Brazil; anacrs1@yahoo.com.br
– name: 2 Department of Biochemistry and Molecular Biology, Federal University of Paraná, Curitiba, Paraná 81531-980, Brazil; mdn@ufpr.br (M.D.N.); lugarciaferreira@gmail.com (L.G.F.); jcassolato@yahoo.com.br (J.E.F.C.)
– name: 3 Laboratory of Biochemistry of Proteins from Animal Venoms, Research and Development Center, Ezequiel Dias Foundation, Belo Horizonte, Minas Gerais 30510-010, Brazil; eladiooswaldo@gmail.com
Author_xml – sequence: 1
  givenname: Ana Cláudia Rodrigues
  surname: da Silva
  fullname: da Silva, Ana Cláudia Rodrigues
  email: anacrs1@yahoo.com.br
  organization: Department of Molecular and Cellular Biology, Federal Fluminense University, Niterói, Rio de Janeiro 24020-141, Brazil. anacrs1@yahoo.com.br
– sequence: 2
  givenname: Maria Eugenia Rabello
  surname: Duarte
  fullname: Duarte, Maria Eugenia Rabello
  email: nosedaeu@ufpr.br
  organization: Department of Biochemistry and Molecular Biology, Federal University of Paraná, Curitiba, Paraná 81531-980, Brazil. nosedaeu@ufpr.br
– sequence: 3
  givenname: Miguel Daniel
  surname: Noseda
  fullname: Noseda, Miguel Daniel
  email: mdn@ufpr.br
  organization: Department of Biochemistry and Molecular Biology, Federal University of Paraná, Curitiba, Paraná 81531-980, Brazil. mdn@ufpr.br
– sequence: 4
  givenname: Luciana Garcia
  surname: Ferreira
  fullname: Ferreira, Luciana Garcia
  email: lugarciaferreira@gmail.com
  organization: Department of Biochemistry and Molecular Biology, Federal University of Paraná, Curitiba, Paraná 81531-980, Brazil. lugarciaferreira@gmail.com
– sequence: 5
  givenname: Juliana Emanuela Fogari
  surname: Cassolato
  fullname: Cassolato, Juliana Emanuela Fogari
  email: jcassolato@yahoo.com.br
  organization: Department of Biochemistry and Molecular Biology, Federal University of Paraná, Curitiba, Paraná 81531-980, Brazil. jcassolato@yahoo.com.br
– sequence: 6
  givenname: Eladio Flores
  surname: Sanchez
  fullname: Sanchez, Eladio Flores
  email: eladiooswaldo@gmail.com
  organization: Laboratory of Biochemistry of Proteins from Animal Venoms, Research and Development Center, Ezequiel Dias Foundation, Belo Horizonte, Minas Gerais 30510-010, Brazil. eladiooswaldo@gmail.com
– sequence: 7
  givenname: Andre Lopes
  orcidid: 0000-0002-5265-5258
  surname: Fuly
  fullname: Fuly, Andre Lopes
  email: andrefuly@id.uff.br
  organization: Department of Molecular and Cellular Biology, Federal Fluminense University, Niterói, Rio de Janeiro 24020-141, Brazil. andrefuly@id.uff.br
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30373238$$D View this record in MEDLINE/PubMed
BookMark eNpdkt1rFDEQwBep2A998Q-QgC8inubrkuyLcBSthYoFra9hNpm9S91Nrsle8QT_d6NXa-tTJjO_-TEMc9jsxRSxaZ4y-lqIlr4ZPVOMUcn4g-aAKUVnNa337sT7zWEpl5SKuWnlo2ZfUKEFF-ag-XmeJoxTgIFcTGEIP2AKKZLUEyDnadgWcG4FOXgkfU4jmVZIPtZ_RLIYloDkBLYZhgAkfd-WNeYRyCsChUAki-q9xli7-pTJ11CrwdeWzxG-YRcmLI-bhz0MBZ_cvEfNxft3X44_zM4-nZweL85mTmo-zZTRXMvWKY6-81pBT5n0vkNgvp-jM4K3Ujvj2o5J4bRzvGOVo0pJI3wvjprTndcnuLTrHEbIW5sg2D-JlJcW8hTcgLZ3Pe0oMsc0la1XnYNWS8kF99xT11bX251rvelG9K5ury7gnvR-JYaVXaZrq7hS3OgqeHEjyOlqg2WyYygOhwEipk2xnHHNWqU5q-jz_9DLtMmxrsryueFGUGpopV7uKJdTKRn722EYtb8vxP67kAo_uzv-Lfr3JMQvWi-5ag
CitedBy_id crossref_primary_10_1007_s13399_023_03922_6
crossref_primary_10_1016_j_carbpol_2018_12_054
crossref_primary_10_1515_znc_2022_0010
crossref_primary_10_3390_md18100514
crossref_primary_10_3390_toxins16040188
crossref_primary_10_1016_j_aquaculture_2022_738596
Cites_doi 10.1023/A:1022997622334
10.1055/s-2006-960804
10.2174/092986710791556069
10.1016/0041-0101(88)90140-7
10.1016/S0140-6736(09)61754-2
10.1016/j.carbpol.2007.06.012
10.1039/b009029h
10.1016/S1043-6618(03)00215-9
10.1007/s10126-016-9722-8
10.1016/j.carbpol.2015.07.055
10.1016/S0041-0101(97)00160-8
10.1590/S0102-695X2011005000057
10.1016/S0006-2952(03)00579-3
10.1515/bot-2012-0197
10.1016/j.jprot.2014.11.011
10.1016/j.toxicon.2009.01.020
10.3390/md11010194
10.1271/bbb.62.1647
10.2174/092986705774370655
10.1016/j.biologicals.2011.02.005
10.3390/toxins10040142
10.1039/c3np70117d
10.7883/yoken1952.13.43
10.1016/j.carres.2008.09.014
10.1016/S0003-9861(78)80015-0
10.1016/S0041-0101(02)00283-0
10.1055/s-2004-827228
10.1016/j.toxicon.2007.10.008
10.1016/j.toxicon.2007.03.010
10.1016/S0006-2952(02)00873-0
10.1016/j.ejmech.2008.02.043
10.1016/S0140-6736(09)61159-4
10.1590/0001-3765201720160488
10.3390/tropicalmed3020042
10.1016/j.bmcl.2006.01.076
10.1590/S0034-8910.2015049005839
10.1080/10826069408010084
10.3390/toxins10080309
10.1016/j.carbpol.2014.09.089
10.3390/md13063761
10.1016/j.trstmh.2009.12.006
ContentType Journal Article
Copyright 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2018 by the authors. 2018
Copyright_xml – notice: 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2018 by the authors. 2018
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7T7
7TN
7X7
7XB
88E
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
BKSAR
C1K
CCPQU
DWQXO
F1W
FR3
FYUFA
GHDGH
GNUQQ
H95
H99
HCIFZ
K9.
L.F
L.G
LK8
M0S
M1P
M7P
P64
PCBAR
PIMPY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.3390/md16110412
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Oceanic Abstracts
ProQuest_Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Natural Science Collection
Earth, Atmospheric & Aquatic Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
ASFA: Aquatic Sciences and Fisheries Abstracts
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources
ASFA: Marine Biotechnology Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Aquatic Science & Fisheries Abstracts (ASFA) Marine Biotechnology Abstracts
Aquatic Science & Fisheries Abstracts (ASFA) Professional
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Medical Database
Biological Science Database
Biotechnology and BioEngineering Abstracts
Earth, Atmospheric & Aquatic Science Database
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
Aquatic Science & Fisheries Abstracts (ASFA) Professional
ProQuest Central Student
Technology Research Database
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest Central
Earth, Atmospheric & Aquatic Science Collection
Health Research Premium Collection
Oceanic Abstracts
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
Aquatic Science & Fisheries Abstracts (ASFA) Marine Biotechnology Abstracts
Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Earth, Atmospheric & Aquatic Science Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ASFA: Aquatic Sciences and Fisheries Abstracts
Engineering Research Database
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE

Publicly Available Content Database
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1660-3397
ExternalDocumentID oai_doaj_org_article_fcf0b0e1c17049d6bca9744232d2d0c9
10_3390_md16110412
30373238
Genre Journal Article
GroupedDBID ---
29M
2WC
3V.
53G
5GY
5VS
7X7
88E
8CJ
8FE
8FH
8FI
8FJ
AADQD
AAHBH
ABUWG
ACGFO
ACIHN
ACPRK
ADBBV
ADRAZ
AEAQA
AENEX
AFKRA
AFRAH
AFZYC
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BKSAR
BPHCQ
BVXVI
CCPQU
CGR
CS3
CUY
CVF
D1J
DIK
DU5
E3Z
EBD
ECM
EDH
EIF
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IPNFZ
KQ8
LK5
LK8
M1P
M48
M7P
M7R
MK0
MODMG
M~E
NPM
O5R
O5S
OK1
P2P
PCBAR
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RNS
RPM
TR2
UKHRP
XSB
AAYXX
CITATION
7T7
7TN
7XB
8FD
8FK
AZQEC
C1K
DWQXO
F1W
FR3
GNUQQ
H95
H99
K9.
L.F
L.G
P64
PQEST
PQUKI
7X8
5PM
ID FETCH-LOGICAL-c472t-6872749c62edbd76af014ddbea1df5ec832947c8c9b143c7cc2b1d76066483df3
IEDL.DBID RPM
ISSN 1660-3397
IngestDate Tue Oct 22 15:12:30 EDT 2024
Tue Sep 17 21:28:26 EDT 2024
Fri Aug 16 01:00:31 EDT 2024
Thu Oct 31 10:36:10 EDT 2024
Thu Nov 21 20:52:06 EST 2024
Sat Sep 28 08:36:47 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords polysaccharide
Bothrops jararaca
Lachesis muta
antivenom
green marine alga
neutralization
snake venom
Gayralia oxysperma
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c472t-6872749c62edbd76af014ddbea1df5ec832947c8c9b143c7cc2b1d76066483df3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-5265-5258
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266287/
PMID 30373238
PQID 2582830080
PQPubID 2032365
ParticipantIDs doaj_primary_oai_doaj_org_article_fcf0b0e1c17049d6bca9744232d2d0c9
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6266287
proquest_miscellaneous_2127196721
proquest_journals_2582830080
crossref_primary_10_3390_md16110412
pubmed_primary_30373238
PublicationCentury 2000
PublicationDate 2018-10-27
PublicationDateYYYYMMDD 2018-10-27
PublicationDate_xml – month: 10
  year: 2018
  text: 2018-10-27
  day: 27
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Marine drugs
PublicationTitleAlternate Mar Drugs
PublicationYear 2018
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References ref12
ref34
ref15
ref37
ref14
ref36
ref31
ref30
ref11
ref33
ref10
ref32
ref2
ref1
ref17
ref39
ref16
ref38
ref19
ref18
Warrell (ref4) 2004; Volume 2
Mohammad (ref13) 2015; 23
Faulkner (ref35) 2002; 19
Kemparaju (ref8) 2010
ref24
ref23
ref45
ref26
ref25
ref20
ref42
ref41
ref22
ref21
ref43
Yamakawa (ref44) 1976; 49
ref28
ref27
ref29
Jeane (ref3) 2015; 114
ref7
ref9
ref6
ref5
ref40
References_xml – ident: ref21
  doi: 10.1023/A:1022997622334
– ident: ref16
  doi: 10.1055/s-2006-960804
– ident: ref39
  doi: 10.2174/092986710791556069
– ident: ref45
  doi: 10.1016/0041-0101(88)90140-7
– volume: Volume 2
  start-page: 709
  year: 2004
  ident: ref4
  article-title: Snakebites in Central and South America: Epidemiology, clinical features, and clinical management
  contributor:
    fullname: Warrell
– ident: ref1
  doi: 10.1016/S0140-6736(09)61754-2
– ident: ref19
  doi: 10.1016/j.carbpol.2007.06.012
– start-page: 237
  year: 2010
  ident: ref8
  article-title: Hyaluronidases, a Neglected Class of Glycosidases from Snake Venom Beyond a Spreading Factor
  contributor:
    fullname: Kemparaju
– volume: 19
  start-page: 1
  year: 2002
  ident: ref35
  article-title: Marine natural products
  publication-title: Nat. Prod. Rep.
  doi: 10.1039/b009029h
  contributor:
    fullname: Faulkner
– ident: ref22
  doi: 10.1016/S1043-6618(03)00215-9
– ident: ref29
  doi: 10.1007/s10126-016-9722-8
– ident: ref23
  doi: 10.1016/j.carbpol.2015.07.055
– ident: ref9
  doi: 10.1016/S0041-0101(97)00160-8
– ident: ref25
  doi: 10.1590/S0102-695X2011005000057
– ident: ref30
  doi: 10.1016/S0006-2952(03)00579-3
– ident: ref24
  doi: 10.1515/bot-2012-0197
– volume: 114
  start-page: 93
  year: 2015
  ident: ref3
  article-title: Venomics and antivenomics of Bothrops erythromelas from five geographic populations within the Caatinga ecoregion of northeastern Brazil
  publication-title: J. Proteomics
  doi: 10.1016/j.jprot.2014.11.011
  contributor:
    fullname: Jeane
– ident: ref32
  doi: 10.1016/j.toxicon.2009.01.020
– ident: ref40
  doi: 10.3390/md11010194
– ident: ref18
  doi: 10.1271/bbb.62.1647
– ident: ref34
  doi: 10.2174/092986705774370655
– ident: ref6
  doi: 10.1016/j.biologicals.2011.02.005
– ident: ref11
  doi: 10.3390/toxins10040142
– ident: ref14
  doi: 10.1039/c3np70117d
– ident: ref43
  doi: 10.7883/yoken1952.13.43
– ident: ref26
  doi: 10.1016/j.carres.2008.09.014
– volume: 49
  start-page: 97
  year: 1976
  ident: ref44
  article-title: Animal, Plant and Microbial
  publication-title: Toxins
  contributor:
    fullname: Yamakawa
– ident: ref42
  doi: 10.1016/S0003-9861(78)80015-0
– volume: 23
  start-page: 871
  year: 2015
  ident: ref13
  article-title: Ethnopharmacological Survey of Medicinal Plants Used by Traditional Healers and Indigenous People in Chittagong Hill Tracts, Bangladesh, for the Treatment of Snakebite
  publication-title: Evid. Based Complement. Alternat. Med.
  contributor:
    fullname: Mohammad
– ident: ref7
  doi: 10.1016/S0041-0101(02)00283-0
– ident: ref17
  doi: 10.1055/s-2004-827228
– ident: ref31
  doi: 10.1016/j.toxicon.2007.10.008
– ident: ref36
  doi: 10.1016/j.toxicon.2007.03.010
– ident: ref41
  doi: 10.1016/S0006-2952(02)00873-0
– ident: ref37
  doi: 10.1016/j.ejmech.2008.02.043
– ident: ref2
  doi: 10.1016/S0140-6736(09)61159-4
– ident: ref38
  doi: 10.1590/0001-3765201720160488
– ident: ref10
  doi: 10.3390/tropicalmed3020042
– ident: ref20
  doi: 10.1016/j.bmcl.2006.01.076
– ident: ref5
  doi: 10.1590/S0034-8910.2015049005839
– ident: ref15
  doi: 10.1080/10826069408010084
– ident: ref12
  doi: 10.3390/toxins10080309
– ident: ref27
  doi: 10.1016/j.carbpol.2014.09.089
– ident: ref28
  doi: 10.3390/md13063761
– ident: ref33
  doi: 10.1016/j.trstmh.2009.12.006
SSID ssj0035894
Score 2.2917814
Snippet Worldwide, snakebites have serious implications for human health. The administration of antivenom is the official treatment used to reverse the toxic...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 412
SubjectTerms Algae
Amputation
Animals
Antivenins - isolation & purification
Antivenins - pharmacology
Antivenins - therapeutic use
Antivenom
Aquatic Organisms - chemistry
Biocompatibility
Blood Coagulation - drug effects
Bothrops
Bothrops jararaca
Chlorophyta - chemistry
Coagulation
Crotalid Venoms - antagonists & inhibitors
Crotalid Venoms - pharmacology
Cytotoxicity
Deformation effects
Deoxy Sugars - isolation & purification
Deoxy Sugars - pharmacology
Deoxy Sugars - therapeutic use
Disease Models, Animal
Gayralia oxysperma
green marine alga
Haemorrhage
Hemolysis - drug effects
Hemorrhage
Humans
In vivo methods and tests
Injection
Lachesis muta
Mannans - isolation & purification
Mannans - pharmacology
Mannans - therapeutic use
Mice
Mice, Inbred BALB C
neutralization
Plant resistance
Plasma
polysaccharide
Polysaccharides
Proteolysis
Snake bites
Snake Bites - blood
Snake Bites - drug therapy
snake venom
Toxicity testing
Venom
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwEB1BT1wQlK9AiwaBetqIOPbayXFbWnoBrdQWcYv8FVixJIjsSkTixzOOs7ssQuLCJYpiJ3IyM_Z7secZ4JXRhrkpc-S8dBBO2rTMXJFy7grDlPdm0NK7vFLvPxZvzoNMznarr7AmLMoDxw_3urZ1ZjLPLFMEZp00VhMEDtOLLneZjal7mdyQqdgH82lRiihGyonUE7knYMOCtNTe8DOo9P8NWv65QvK3IefiHtwdsSLOYhvvwy3fHMLJPIpN9xO83uVOdRM8wflOhrp_AD_n7SosBaIn3KwWyzHfEtsaNc7bZd9pG1KuFs5jyDFBQoL4TodkQJwtP2mPb3U__AXB9kcf9MS_6gnqDnWDs2boJOkmgrz4YRHUkh3dcdXoL94QiO0ews3F-fXZZTrutZBaofJVKgsCMqK0MvfOOCV1TdzJOeM1c_XUWwr8Uihb2NIQwrLK2pyMrAL9EQV3NX8EB03b-CeAU04Us2ZSel4IU3ptpBd0XmaeuHguEni5MUH1LUpqVERFgqGqnaESOA3W2dYIMtjDBXKOanSO6l_OkcDRxrbVGJtdlYeZQh6gcgIvtsUUVWGqRDe-XVMdlivqm4geJ_A4usK2JTToK05IJwG15yR7Td0vaRafB-VuYo-SKOrT__Fuz-AOgbdBmzdXR3Cw-r72x3C7c-vnQyz8ApbqEmQ
  priority: 102
  providerName: Directory of Open Access Journals
Title Potential Utilization of a Polysaccharide from the Marine Algae Gayralia oxysperma , as an Antivenom for Viperidae Snakebites
URI https://www.ncbi.nlm.nih.gov/pubmed/30373238
https://www.proquest.com/docview/2582830080
https://search.proquest.com/docview/2127196721
https://pubmed.ncbi.nlm.nih.gov/PMC6266287
https://doaj.org/article/fcf0b0e1c17049d6bca9744232d2d0c9
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb5wwEB11c6hyqfpd2jRy1SqnJQs2YDhu06S5pEJKUvWG_EWCugtR2JWK1B_fsYHdbNVTLwhhG1maGfOePfMA-CSFDHUcanRevEQ6UX4W6NRnTKcy5MZIp6V3fsm__Ui_nFqZnHishXFJ-0pWx_VieVxXty638m6pZmOe2Cy_OEEQniDSn01ggthwpOj98sviNIt6HVKGfB55PWKa0KpK7cNjXK85o7YW5cFHyGn1_wtg_p0n-eDDc_YUngyIkcz7mT2DR6Z-Dkd5LzndTcnVtoKqnZIjkm_FqLsX8DtvVjYhCN9wvaoWQ9UlaUoiSN4sulYoW3hVaUNspQlBPEguhC0JJPPFjTDkq-jcXghpfnVWVXwppkS0RNRkXrulEgch8CXfK6uZrHHEZS1-GolQtn0J12enVyfn_vDHBV9FnK78JEU4E2UqoUZLzRNRIoPSWhoR6jI2CsM_i7hKVSYRZymuFEVTc0uCopTpkr2CvbqpzRsgMUOiWYZJYlgaycwImZgI77PAICOnkQcfRxMUd72wRoGExNqs2NrMg8_WOpseVgzbPWjub4rBJYpSlYEMTKhCjnxHJ1IJZEn2BFpTHajMg4PRtsUQoW1B7Xkhs4DZgw-bZowte2AiatOssU9IOa5QSJI9eN27wmYmoyt5wHecZGequy3ozk6_e3Dft_898h3sI25zsryUH8De6n5t3sOk1etDt6dw6CLiDz3rE4A
link.rule.ids 230,315,729,782,786,866,887,2106,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB7RIkEvvB-GAotAPcWN7bW99jGUliCaKlJTxM3al4tFYld1ImGJH8_s2k4axKkXy_LuWivN7Oz3eWc-A3wUXPgq8hU6L15CFUs39VTiUqoS4TOthdXSG5-zsx_J52MjkxP1tTA2aV-K4rCcLw7L4qfNrbxayGGfJzacTo4QhMeI9Ic7cBfXq-f1JL0NwDRK0rBVIqXI6JHZI6rxja7UHtzDiM1oYKpRbmxDVq3_fxDz30zJG1vPycNbTvoRPOiwJhm1zY_hji6fwMG0FatuBmS2qb2qB-SATDcy1s1T-DOtliaVCN9wsSzmXb0mqXLCybSaNzWXpmSrUJqYGhWCSJJMuCkmJKP5JdfkC2_sVxRS_W6MHvmCDwivCS_JqLRBFgchZCbfC6O2rHDEecl_aYEguH4GFyfHs6Ox2_2rwZUhC5ZunCAQClMZB1oJxWKeI_dSSmjuqzzSEgNHGjKZyFQgQpNMygCdhBn6FCZU5fQ57JZVqV8CiShS1NyPY02TUKSai1iHeJ96Grl8EDrwoTdddtVKcmRIZYyts42tHfhkrLruYWS07YPq-jLr7JLlMveEp33pM2RKKhaSI78yZ9cqUJ5MHdjvfSLr1nadBeakkRqo7cD7dTOuSnPUwktdrbCPHzCMbUivHXjRutB6Jr0LOsC2nGtrqtst6FNW-bvzoVe3HvkO7o9nk9Ps9OvZt9ewh-jPivsGbB92l9cr_QZ2arV6a9fTX81oKBg
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RIlW98H6kFDAC9bTpJnY2To5L26UIWkVqi7hFfqVE3U1Wza5EJH484zx2u4gTXKIotiNLM558XzzzGeCDFNLXI1-j8-Il0KFyY09HLmM6kj43RjZaeqcX_Px7dHxiZXJWR301SftK5ofFdHZY5D-a3Mr5TA37PLFhcnaEIDxEpD-c62y4BfdxzXq0J-ptEGajKA5aNVKGrB7ZPSIb32pL7cIORm3OqK1IufMpahT7_wYz_8yWvPP5mTz8j4k_ggcd5iTjtstjuGeKJ3CQtKLV9YBcrmuwqgE5IMlazrp-Cr-ScmFTivANV4t82tVtkjIjgiTltK6EsqVbuTbE1qoQRJTkTNiiQjKeXgtDPom6-ZtCyp-11SWfiQERFREFGRdNsMVBCJ3Jt9yqLmsccVGIGyMRDFfP4Gpycnl06nZnNrgq4HThhhECoiBWITVaah6KDDmY1tIIX2cjozCAxAFXkYolIjXFlaLoLNzSqCBiOmPPYbsoC_MSyIghVc38MDQsCmRshAxNgPexZ5DT08CB97350nkrzZEipbH2Ttf2duCjteyqh5XTbh6Ut9dpZ5s0U5knPeMrnyNj0qFUAnmW3cPWVHsqdmC_94u0W-NVSu2OI7OQ24F3q2ZcnXbLRRSmXGIfn3KMcUizHXjRutFqJr0bOsA3HGxjqpst6FeNAnjnR3v_PPIt7CTHk_Tr5_Mvr2AXQWCj8Uv5PmwvbpfmNWxVevmmWVK_AfxzKpg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Potential+Utilization+of+a+Polysaccharide+from+the+Marine+Algae+Gayralia+oxysperma%2C+as+an+Antivenom+for+Viperidae+Snakebites&rft.jtitle=Marine+drugs&rft.au=da+Silva%2C+Ana+Cl%C3%A1udia+Rodrigues&rft.au=Duarte%2C+Maria+Eugenia+Rabello&rft.au=Noseda%2C+Miguel+Daniel&rft.au=Ferreira%2C+Luciana+Garcia&rft.date=2018-10-27&rft.eissn=1660-3397&rft.volume=16&rft.issue=11&rft_id=info:doi/10.3390%2Fmd16110412&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1660-3397&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1660-3397&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1660-3397&client=summon